ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,600Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 1677

$1.72M Total Retail Price of All Prescriptions

Rank: 14 out of 1677

685 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 685 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 685 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 24,116 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
NAMENDA 1,300 1,174 1 39
AMLODIPINE BESYLATE 1,225 1,055 2 2
LISINOPRIL 1,011 807 3 3
HYDROCODONE-ACETAMINOPHEN 993 798 S3 4 4
DONEPEZIL HCL 768 704 5 30
RANITIDINE HCL 736 568 6 18
METOPROLOL TARTRATE 697 625 7 12
PRAVASTATIN SODIUM 690 619 8 10
FAMOTIDINE 666 467 9 41
FUROSEMIDE 629 530 10 8
MIRTAZAPINE 604 485 11 62
SIMVASTATIN 518 435 12 1
CARVEDILOL 511 386 13 20
SERTRALINE HCL 510 415 14 26
CITALOPRAM HBR 501 404 15 22
POTASSIUM CHLORIDE 482 425 16 14
RISPERIDONE 478 360 17 60
GABAPENTIN 476 381 18 11
QUETIAPINE FUMARATE 427 296 19 77
WARFARIN SODIUM 424 290 20 24
LEVOTHYROXINE SODIUM 415 376 21 5
HYDRALAZINE HCL 415 313 21 69
TRAMADOL HCL 380 311 23 16
NOVOLIN R 358 268 24 133
LANTUS 353 266 25 44
TRAZODONE HCL 337 281 26 37
OMEPRAZOLE 323 260 27 6
EXELON 300 263 28 119
CLONIDINE HCL 290 193 29 36
VALPROIC ACID 275 171 30 211
DIVALPROEX SODIUM 271 179 31 111
LEVETIRACETAM 266 174 32 116
GLIPIZIDE 238 205 33 56
ISOSORBIDE MONONITRATE ER 228 197 34 73
NOVOLOG 227 170 35 117
SANTYL 221 160 36 187
CLOPIDOGREL 220 169 37 32
OXYCODONE-ACETAMINOPHEN 211 160 S2 38 122
METFORMIN HCL 209 125 39 7
HYDROCHLOROTHIAZIDE 200 148 40 9
BACLOFEN 185 116 41 142
NAPROXEN 175 154 42 87
PLAVIX 163 128 43 47
SEROQUEL 158 108 44 151
RAMIPRIL 150 121 45 118
CIPROFLOXACIN HCL 145 119 46 57
METOPROLOL SUCCINATE 144 112 47 23
BENZTROPINE MESYLATE 141 55 R 48 176
AMOX TR-POTASSIUM CLAVULANATE 133 106 49 126
PHENYTOIN SODIUM EXTENDED 132 80 50 112
CYMBALTA 131 86 51 58
ATORVASTATIN CALCIUM 125 90 52 13
LATANOPROST 122 113 53 204
ATENOLOL 120 92 54 21
TRAVATAN Z 120 106 54 231
LOSARTAN POTASSIUM 119 106 56 25
ALBUTEROL SULFATE 115 110 57 135
KLOR-CON M20 114 84 58 65
ESCITALOPRAM OXALATE 113 104 59 80
ADVAIR DISKUS 111 100 60 54
TAMSULOSIN HCL 109 68 61 34
LEVEMIR 106 66 62 157
DIVALPROEX SODIUM ER 106 69 62 202
DIGOXIN 105 94 64 71
NYSTATIN 98 79 65 185
POLYETHYLENE GLYCOL 3350 98 76 65 76
FINASTERIDE 98 85 65 130
SULFAMETHOXAZOLE-TRIMETHOPRIM 97 78 68 85
DIOVAN 96 83 69 45
LEVOFLOXACIN 92 83 70 84
LIDODERM 92 78 70 160
MORPHINE SULFATE ER 91 82 S2 72 140
ALENDRONATE SODIUM 87 87 73 43
DILTIAZEM HCL 87 87 73 218
NIFEDIPINE ER 85 64 75 98
ZOLPIDEM TARTRATE 85 49 75 15
ROPINIROLE HCL 84 84 77 79
CARBIDOPA-LEVODOPA 83 74 78 131
MUPIROCIN 82 60 79 170
METHADONE HCL 82 18 S2 79 168
NUEDEXTA 81 63 81 241
DOXAZOSIN MESYLATE 80 63 82 90
ALLOPURINOL 80 65 82 31
VENLAFAXINE HCL ER 80 59 82 92
PREDNISONE 78 72 85 40
FLUOXETINE HCL 75 46 86 49
METOCLOPRAMIDE HCL 74 42 87 124
RENVELA 74 41 87 300
TRIAMTERENE-HCTZ 72 60 89 61
IPRATROPIUM BROMIDE 72 70 89 171
PROMETHAZINE HCL 71 43 R 91 64
KLOR-CON M10 71 47 91 167
HUMALOG 70 61 93 224
SPIRIVA 69 52 94 74
ONDANSETRON HCL 68 38 95 232
COLCRYS 66 57 96 141
TIMOLOL MALEATE 66 61 96 320
LABETALOL HCL 65 26 98 195
PANTOPRAZOLE SODIUM 63 49 99 46
CEPHALEXIN 63 55 99 99
FENTANYL 61 29 S2 101 103
NOVOLIN 70-30 61 48 101 155
HALOPERIDOL 60 32 103 229
IBUPROFEN 58 39 104 83
NITROGLYCERIN PATCH 57 57 105 184
OXYBUTYNIN CHLORIDE ER 55 49 106 173
OXYBUTYNIN CHLORIDE 55 55 106 149
MELOXICAM 52 36 108 27
PHENYTOIN 52 42 108 261
GLIPIZIDE ER 51 39 110 78
NITROFURANTOIN MONO-MACRO 51 40 110 177
CLONIDINE 50 27 112 291
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.